Back
Global X S&P 500 ESG Covered Call ETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
41
XYLE
Global X S&P 500 ESG Covered Call ETF
Last Price:
26.42
Seasonality Move:
5.03%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
320.26
Seasonality Move:
31.67%
Sell
41
Global X S&P 500 ESG Covered Call ETF (XYLE)
is a Sell
Is Global X S&P 500 ESG Covered Call ETF a Buy, Sell or Hold?
- The current Global X S&P 500 ESG Covered Call ETF [XYLE] share price is $26.34. The Score for XYLE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- XYLE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XYLE Stock Price Chart
What is Global X S&P 500 ESG Covered Call ETF's stock price today?
-
The Global X S&P 500 ESG Covered Call ETF share price today is $26.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XYLE is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
XYLE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 35.05 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.57 - 26.85) | Sell |
Bollinger Bands (100): | (25.75 - 26.69) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 74.74 | Buy |
Chaikin Money Flow: | 898979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (203.29 - 223.91) | Buy |
Bollinger Bands (100): | (221.8 - 277.54) | Buy |
XYLE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.64 | Sell |
20-day SMA: | 26.74 | Sell |
50-day SMA: | 26.54 | Sell |
200-day SMA: | 25.95 | Buy |
8-day EMA: | 26.63 | Sell |
20-day EMA: | 26.67 | Sell |
50-day EMA: | 26.52 | Sell |
200-day EMA: | 25.98 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 216.22 | Buy |
20-day SMA: | 214.16 | Buy |
50-day SMA: | 227.04 | Buy |
200-day SMA: | 240.71 | Buy |
8-day EMA: | 223.2 | Buy |
20-day EMA: | 218.42 | Buy |
50-day EMA: | 226.38 | Buy |
200-day EMA: | 233.63 | Buy |
Global X S&P 500 ESG Covered Call ETF Earnings Growth & XYLE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
Global X S&P 500 ESG Covered Call ETF Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |